Document Detail


Sensory disturbances associated with serotonin reuptake inhibitors: brief review.
MedLine Citation:
PMID:  20373472     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Serotonin reuptake inhibitors (SRIs) are occasionally associated with sensory symptoms, which are one of the less recognized adverse effects. A PUBMED search supplemented with manual search was made to review the relevant literature. Anesthesia, paresthesia, and mastalgia have been reported to occur with this group of medications. The possible pathophysiology and management strategies are discussed.
Authors:
Samir Kumar Praharaj; Manu Arora; Sujit Sarkhel
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Human psychopharmacology     Volume:  25     ISSN:  1099-1077     ISO Abbreviation:  Hum Psychopharmacol     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-04-07     Completed Date:  2010-11-04     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8702539     Medline TA:  Hum Psychopharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  216-21     Citation Subset:  IM    
Copyright Information:
Copyright (c) 2010 John Wiley & Sons, Ltd.
Affiliation:
Central Institute of Psychiatry, Kanke, Ranchi, India. samirpsyche@yahoo.co.in
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Clinical Trials as Topic / methods
Humans
Mental Disorders / drug therapy,  psychology
Paresthesia / chemically induced,  diagnosis,  prevention & control
Risk Factors
Sensation Disorders / chemically induced*,  diagnosis*,  prevention & control
Serotonin Uptake Inhibitors / adverse effects*,  therapeutic use
Chemical
Reg. No./Substance:
0/Serotonin Uptake Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A psychoneuroimmunological review on cytokines involved in antidepressant treatment response.
Next Document:  Impact of the novel antidepressant agomelatine on disturbed sleep-wake cycles in depressed patients.